The Nuffield Department of Clinical Medicine is part of the Medical Sciences Division. It hosts one of the largest groupings of Biomedical Researchers in the University Sector, and is also responsible for a significant part of the teaching of clinical medical students with the Oxford Medical School.
Oxford Biotech would like to invite you to an evening on the Future of Drug Discovery, featuring a range of speakers including Professor Chas Bountra from the Structural Genomics Consortium, on the 4th of December at 6:30PM in the Medical Sciences Teaching Theatre. This event is open to Oxford Biotech members only. In order to register for this event, please first join Oxford Biotech. Membership is free and allows you to take advantage of our many benefits.
Almost 200 people have received a candidate Ebola vaccine in little more than two months in safety trials carried out in the USA, UK, Mali and Switzerland. At the Jenner Institute within the University of Oxford, the 60th and last healthy volunteer is due to receive the vaccine on Tuesday 18th of November. The Ebola vaccine was developed by the US National Institutes of Health (NIH) and GSK. These first trials in humans have been fast-tracked in ...
A clinical trial is to be carried out in West Africa to see whether a novel antiviral drug called brincidofovir is effective against Ebola, subject to regulatory approval. The trial, involving an international team led by Professor Peter Horby, will take place in an Ebola treatment centre run by Médecins Sans Frontières (MSF). Brincidofovir is an experimental antiviral drug made by Chimerix of Durham in North Carolina, USA.
The focus of Dr Christopher Yau is the development of computational statistical methods for applications in genetics and genomics. His aim is to develop methods and tools that can be widely used by specialists and non-specialists alike for research and clinical practice in cancer.
Thu 27th Nov 2014 from 13:00 to 14:00, Lecture Theatre 1, John Radcliffe Hospital
Acute General Medicine Firm B: “TBA”, Speaker to be confirmed
The Jenner Institute: “Global Progress in TB vaccine development”, Prof Helen McShane